, Tracking Stock Market Picks
Enter Symbol:
AcelRx Pharmaceuticals Inc (ACRX) [hlAlert]

down 19.88 %

AcelRx Pharmaceuticals Inc (ACRX) rated Buy by Jefferies

Posted on: Monday,  Apr 8, 2013  8:25 AM ET by Jefferies

Jefferies rated Buy AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) on 04/08/2013, when the stock price was $5.38. Since
then, AcelRx Pharmaceuticals Inc has lost 19.89% as of 01/06/2016's recent price of $4.31.
If you would have followed this Jefferies's recommendation on ACRX, you would have lost 19.88% of your investment in 1003 days.

AcelRx Pharmaceuticals, Inc. is a development-stage company. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. It has completed Phase 2 clinical development for two additional product candidates, the Sufentanil NanoTab BTP Management System, or ARX-02, for the treatment of cancer breakthrough pain (BTP), and the Sufentanil/Triazolam NanoTab, or ARX-03, designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician?s office. The Company is preparing to initiate two Phase 3 clinical trials for its product candidate, the Sufentanil NanoTab PCA System, or ARX-01. ARX-02 is a product candidate for the treatment of cancer patients who suffer from breakthrough pain. ARX-03 Sufentanil/Triazolam NanoTab is a single, fixed-dose sublingual product candidate.

Jefferiess' research efforts cover U.S. & International equity, high yield, convertibles, derivatives and option strategies, investment grade fixed income, post-reorganization securities, as well as special situations and quantitative research. Our team of more than 150 research professionals covers nearly 1,200 companies in more than 40 industries worldwide. Our analysts focus on identifying emerging industry themes while providing in-depth, thought provoking, objective research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/8/2013 8:25 AM Buy
as of 12/13/2013
1 Week down  -5.85 %
1 Month up  4.85 %
3 Months down  -23.22 %
1 YTD up  52.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy